Lactoferrin is dubbed the✨wonder molecule✨
Here are 5 things you need to know about this animal-based protein, which can now be made without animal intervention 🥛
Iron is essential for many body functions, including carrying oxygen in red blood cells.
However, free iron can cause damage through free radical production.
🥛 Enter lactoferrin, an iron-binding protein found in mammalian breast milk
Lactoferrin:
- Increases iron absorption
- Prevents microbial growth
- Protects against breast cancer
- Protects against neonatal sepsis
- Improves gut health
- Aids in wound healing
Lactoferrin is seeing significant demand in infant care, health care, biopharmaceutical applications, and the fitness and wellness sector.
The problem?
👎 Low expression levels: It is expressed in extremely low levels in the body. Cows produce <0.1 mg/mL, while breastfeeding humans can produce <5 mg/mL of lactoferrin.
Get Tarika Vijayaraghavan, Ph.D. 🔬’s stories in your inbox
Join Medium for free to get updates from this writer.
In a more technical sense, this poor expression can be attributed to
- Transcriptional regulation: how is lactoferrin produced on a fundamental level?
- Tissue-specific expression: which cell type produces the most lactoferrin, and how can physiology affect lactoferrin production in different tissues?
- Cellular microenvironment influences: are the cells getting adequate nutrients?
💰 High cost: Pure lactoferrin sells for USD 400–3000/kg in the market, making it a highly premium ingredient. Today, it takes 10,000 litres of milk to produce and extract 1 kg lactoferrin (~0.1 g/l), driving costs and creating a supply bottleneck.
Fortunately, scientists have programmed microbes and cells to produce significantly higher lactoferrin concentrations for pharmaceutical and food-grade applications.
Here are 5 things about animal-free recombinant lactoferrin to stay updated on this space —
1. Market and Technology
Helaina, TurtleTree Labs, De Novo Food Labs, All G Foods and Wilk are some of the prominent companies currently producing food-grade lactoferrin at the lab/pilot scale. Wilk produces human lactoferrin via mammary cells, whereas other companies engineer and ferment microbes (Pichia pastoris, mostly) to secrete and purify bovine and/or human lactoferrin.
2. Academia suggests cost reduction techniques
Aspergillus awamori, a koji strain used in animal feed and enzyme production, serves as an excellent host for the production of lactoferrin, as documented in this peer-reviewed research. Researchers have demonstrated the capability of the strain in producing over 5g/L of recombinant lactoferrin while driving down the cost to <$1/g (>2x cost reduction compared to conventional lactoferrin). Plant molecular farming is another promising platform to express high levels of recombinant lactoferrin, although the unit economics are still on the higher end of the spectrum ($5.9 per 1g of lactoferrin).
3. Investments
The five companies listed above have collectively secured over 160 million USD since 2019 to produce recombinant lactoferrin.
4. Regulations
In November 2024, All G became the world’s first company to attain regulatory approval in China for its recombinant bovine Lactoferrin (rLF). Shortly after, in December 2024, All G announced that it has also received a self-affirmed GRAS (generally regarded as safe) status, which takes it a step closer to selling its rLF in the US market.
TurtleTree Labs has also achieved a self-affirmed GRAS status and a vegan certification to bolster its go-to-market strategy for its bovine lactoferrin product (LF+).
5. Dairy Industry Eyes Opportunity
FrieslandCampina and Danone are placing their bets on recombinant lactoferrin. Dutch-based dairy giant FrieslandCampina partnered with the synthetic biology platform TripleBar to produce sustainably sourced lactoferrin efficiently. Danone’s investment in Wilk suggests a keen interest in producing high-value animal-free dairy proteins, including recombinant lactoferrin.
